Long-term contraception by steroid-releasing implants. II A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women-Reference-Cited by-同舟云学术

Long-term contraception by steroid-releasing implants. II A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women

Published:1975-05 Issue:5 Volume:11 Page:505-521
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Bhatnagar Shakuntala,Srivastava U.K.,Takkar D.,Chandra V.L.,Hingorani V.,Laumas K.R.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference21 articles.

1. Single administration of hormones for long-term control of reproductive function;Segal,1967

2. Effects of subcutaneous implantation or intrauterine insertion of silastic tube containing steroids on the fertility of rats;Casas;Biol. Reprod.,1970

3. Prevention of pregnancy in the rabbit by subcutaneous implantation of silastic tube containing oestrogen;Chang;Nature (London),1970

4. Sustained release hormonal preparations: 4. Biological effectivenes of steroid hormones;Chang;Fertil. Steril.,1970

5. Sustained release hormonal preparations: 3. Biological effectiveness of 6-methyl-17α-acetoxypregna-4, 6-diene-3, 20-dione;Chang;Steroids,1968

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal Health Markets and Opportunities: Companion Animal Landscape;Advances in Delivery Science and Technology;2012-09-15

2. Current status of fertility control methods in India;Journal of Biosciences;2001-11

3. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects**This work was undertaken as part of the Contraceptive Development Program sponsored and coordinated by the International Committee for Contraception Research of the Population Council, Inc., New York, New York.††Financial support was provided by the George J. Hecht Fund, The Mellon Foundation, The Rockefeller Foundation, and the United States Agency for International Development through the Population Council, Inc., New York, New York as well as the Paulo Foundation, Helsinki, Finland. The content of this report does not necessarily reflect the policy of any of the funding sources.;Fertility and Sterility;1992-12

4. Bioavailability of norethindrone and menstrual pattern after insertion of norethindrone acetate implants in rhesus monkeys;Contraception;1991-09

5. Particle size and release of norethindrone acetate through silastic tubing: an in vitro and in vivo study;International Journal of Pharmaceutics;1990-09